Home > Insider Trading > Filing (0001708138-21-000020)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226689	Neil Stahl	777 Old Saw Mill River Road Tarrytown NY 10591	Evp Research And Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-02-25	435	$0.00	24,280	No	5	G	Direct
Common Stock	Acquisiton	2021-05-14	40,000	$179.13	64,280	No	4	M	Direct
Common Stock	Disposition	2021-05-14	27,775	$516.69	36,505	No	4	F	Direct
Common Stock	Acquisiton	2021-05-14	12,500	$52.03	49,005	No	4	M	Direct
Common Stock	Disposition	2021-05-14	7,204	$516.69	41,801	No	4	F	Direct
Common Stock	Disposition	2021-05-17	3,379	$518.63	38,422	No	4	S	Direct
Common Stock	Disposition	2021-05-17	10,336	$519.47	28,086	No	4	S	Direct
Common Stock	Disposition	2021-05-17	3,806	$520.17	24,280	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	G	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-05-14	12,500	$0.00	12,500	$52.03
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-05-14	40,000	$0.00	40,000	$179.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-12-16	No	4	M	Direct
72,500		2022-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,787	Indirect	By 401(k) Plan
Common Stock	9,134	Indirect	by 2019 GRAT

Footnotes

Represents volume-weighted average price of sales of 3,379 shares of Company stock on May 17, 2021 at prices ranging from $518.02 to $518.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price.
Represents volume-weighted average price of sales of 10,336 shares of Company stock on May 17, 2021 at prices ranging from $519.00 to $519.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price.
Represents volume-weighted average price of sales of 3,806 shares of Company stock on May 17, 2021 at prices ranging from $520.02 to $520.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price.
The option became exercisable on December 31, 2014, based upon the satisfaction by the Company of certain performance criteria during the period ended December 31, 2014.
The stock option award vested in four equal annual installments, commencing one year after the date of grant.